https://www.bstquarterly.com/article/the-future-of-molecular-imaging/ 2025-10-02T20:33:31+00:00 https://www.bstquarterly.com/article/new-alzheimers-diagnostic-criteria-are-finalized/ 2025-10-02T20:19:49+00:00 https://www.bstquarterly.com/article/lower-cholesterol-may-fight-infections/ 2025-10-02T20:15:52+00:00 https://www.bstquarterly.com/article/kedrion-launches-fda-approved-gammaked-in-the-u-s-market/ 2025-10-02T20:11:11+00:00 https://www.bstquarterly.com/article/study-to-assess-safety-of-meningitis-vaccine-during-pregnancy/ 2025-10-02T20:03:41+00:00 https://www.bstquarterly.com/article/test-can-predict-immune-responses-to-flu-shots/ 2025-10-02T19:04:59+00:00 https://www.bstquarterly.com/article/hpv-vaccine-reduces-cervical-abnormalities/ 2025-10-02T18:58:45+00:00 https://www.bstquarterly.com/article/study-tests-an-adjuvant-to-vaccinate-newborns/ 2025-10-02T14:24:40+00:00 https://www.bstquarterly.com/article/grant-makes-needle-free-vaccine-a-reality/ 2025-10-02T14:18:46+00:00 https://www.bstquarterly.com/article/fda-approves-menactra-for-infants-from-9-months/ 2025-10-02T14:15:02+00:00 https://www.bstquarterly.com/article/fda-approves-rituxan-for-two-rare-disorders/ 2025-10-02T14:07:54+00:00 https://www.bstquarterly.com/article/vaccine-prevents-heroin-high-in-animals/ 2025-10-02T14:04:12+00:00 https://www.bstquarterly.com/article/baxter-receives-fda-approval-for-gammagard-liquid/ 2025-10-02T12:53:37+00:00 https://www.bstquarterly.com/article/legislation-protects-the-treatment-of-rare-diseases/ 2025-10-02T12:26:35+00:00 https://www.bstquarterly.com/article/healthcare-reform-rule-bans-unreasonable-premium-increases/ 2025-10-02T12:21:15+00:00 https://www.bstquarterly.com/article/part-d-drug-premiums-to-decrease-in-2012/ 2025-10-01T21:13:33+00:00 https://www.bstquarterly.com/article/eeoc-issues-final-regulations-interpreting-the-ada-amendments-act/ 2025-10-01T21:08:45+00:00 https://www.bstquarterly.com/article/stis-new-vaccines-and-expanding-recommendations/ 2025-10-01T18:57:15+00:00 https://www.bstquarterly.com/article/travel-vaccines-whats-needed-and-why/ 2025-10-01T18:56:37+00:00 https://www.bstquarterly.com/article/can-inverse-vaccines-cure-autoimmunity/ 2025-10-01T18:55:50+00:00 https://www.bstquarterly.com/article/university-of-toledo-receives-nih-funds-for-fungal-infection-research/ 2025-10-01T18:53:55+00:00 https://www.bstquarterly.com/article/pmdd-a-physicians-perspective/ 2025-10-01T18:52:31+00:00 https://www.bstquarterly.com/article/argenx-is-conducting-a-phase-iv-study-to-assess-efgartigimod-ph20-sc-to-treat-adult-cidp-patients/ 2025-10-01T18:48:11+00:00 https://www.bstquarterly.com/article/ai-assistants-offset-nursing-workload/ 2025-10-01T18:47:49+00:00 https://www.bstquarterly.com/article/2026-proposed-payments-outpatient-settings-and-physician-offices/ 2025-10-01T18:47:25+00:00 https://www.bstquarterly.com/article/less-pain-and-shorter-convalescence-with-fibrin-sealant-vs-tacks-in-mesh-fixation-after-laparoscopic-hernia-repair/ 2025-09-30T19:38:00+00:00 https://www.bstquarterly.com/article/ivig-produces-sustained-long-term-clinical-remission-in-patients-with-epidermolysis-bullosa-acquisita/ 2025-09-30T19:32:12+00:00 https://www.bstquarterly.com/article/human-albumin-improves-endothelial-dysfunction-and-survival-in-experimental-endotoxemia-model/ 2025-09-30T19:26:10+00:00 https://www.bstquarterly.com/article/the-heart-of-the-matter/ 2025-09-30T19:15:07+00:00 https://www.bstquarterly.com/article/leading-with-diplomacy-abbie-cornett/ 2025-09-30T19:04:57+00:00 https://www.bstquarterly.com/article/advancing-healthcare-from-testing-to-treatment/ 2025-09-30T19:02:07+00:00 https://www.bstquarterly.com/article/inspirational-leadership-dr-ronald-sokol/ 2025-09-30T19:00:47+00:00 https://www.bstquarterly.com/article/frontrunner-solutions-in-genetic-testing-diagnostics/ 2025-09-30T18:59:38+00:00 https://www.bstquarterly.com/article/a-vision-for-global-leadership-paolo-marcucci-president-and-ceo-kedrion/ 2025-09-30T18:58:35+00:00 https://www.bstquarterly.com/article/leading-the-way-in-vaccine-innovation/ 2025-09-30T18:57:06+00:00 https://www.bstquarterly.com/article/meeting-the-needs-of-patients-globally/ 2025-09-30T18:55:55+00:00 https://www.bstquarterly.com/article/new-against-the-flu/ 2025-09-30T18:43:13+00:00 https://www.bstquarterly.com/article/myths-and-facts-stroke/ 2025-09-30T17:17:53+00:00 https://www.bstquarterly.com/article/cancer-treatment-and-care-promising-next-steps/ 2025-09-30T17:02:29+00:00 https://www.bstquarterly.com/article/pharma5-five-challenges-of-implementing-ai/ 2025-10-01T07:00:15+00:00 https://www.bstquarterly.com/article/the-state-of-acquired-hemophilia/ 2025-09-30T12:20:02+00:00 https://www.bstquarterly.com/article/immune-globulin-reimbursement/ 2025-09-29T20:24:34+00:00 https://www.bstquarterly.com/article/individual-ig-dosing/ 2025-09-29T19:47:09+00:00 https://www.bstquarterly.com/article/fda-fast-tracks-immunotherapy-for-her2-positive-breast-cancer-recurrence/ 2025-09-29T18:58:59+00:00 https://www.bstquarterly.com/article/immune-globulin-therapy-the-investigational-frontier/ 2025-09-29T16:25:04+00:00 https://www.bstquarterly.com/article/top-line-results-for-phase-iii-study-of-hyq-in-pidd-patients/ 2025-09-29T15:51:10+00:00 https://www.bstquarterly.com/article/flu-vaccine-production-to-double-by-2015/ 2025-09-29T15:46:11+00:00 https://www.bstquarterly.com/article/urine-test-could-warn-about-cognitive-decline/ 2025-09-29T15:41:16+00:00 https://www.bstquarterly.com/article/octagam-5-returns-to-market-in-u-s-and-europe/ 2025-09-29T15:36:34+00:00 https://www.bstquarterly.com/article/bouncer-protein-halts-rheumatoid-arthritis/ 2025-09-29T15:22:40+00:00 https://www.bstquarterly.com/article/insurance-premiums-up-9-percent-in-2011/ 2025-09-29T15:19:01+00:00 https://www.bstquarterly.com/article/uninsured-unable-to-pay-hospital-bills/ 2025-09-29T15:14:50+00:00 https://www.bstquarterly.com/article/copd-patients-have-higher-risk-of-shingles/ 2025-09-29T15:07:46+00:00 https://www.bstquarterly.com/article/nobel-medicine-prize-awarded-to-tumor-vaccine-developers/ 2025-09-29T14:49:01+00:00 https://www.bstquarterly.com/article/healthwell-foundation-launches-sle-fund/ 2025-09-29T14:44:26+00:00 https://www.bstquarterly.com/article/modified-vaccine-may-prevent-malaria/ 2025-09-29T14:41:09+00:00 https://www.bstquarterly.com/article/cdc-to-launch-streamlined-vaccine-tracking-system/ 2025-09-24T19:30:23+00:00 https://www.bstquarterly.com/article/fda-approves-first-ms-oral-treatment/ 2025-09-24T19:26:51+00:00 https://www.bstquarterly.com/article/teens-young-adults-have-increase-in-stroke-prevalence/ 2025-09-24T19:26:13+00:00 https://www.bstquarterly.com/article/medicare-part-b-premiums-lower-than-projected-for-2012/ 2025-09-24T19:25:38+00:00 https://www.bstquarterly.com/article/40m-in-funds-available-for-chronic-disease-prevention/ 2025-09-24T19:09:09+00:00 https://www.bstquarterly.com/article/new-pioneer-aco-model-proposed/ 2025-09-24T19:05:14+00:00 https://www.bstquarterly.com/article/twelve-new-diagnoses-added-to-compassionate-allowances-list/ 2025-09-24T19:01:04+00:00 https://www.bstquarterly.com/article/supreme-court-to-rule-on-healthcare-law-constitutionality/ 2025-09-24T18:55:12+00:00 https://www.bstquarterly.com/article/hhs-launches-initiative-for-primary-care-practices/ 2025-09-24T18:50:40+00:00 https://www.bstquarterly.com/article/hhs-releases-aco-final-regulations/ 2025-09-24T18:46:16+00:00 https://www.bstquarterly.com/article/ig-the-challenge-the-promise-the-future/ 2025-09-24T18:42:49+00:00 https://www.bstquarterly.com/article/danger-ahead-the-growing-safety-challenges/ 2025-09-24T18:20:01+00:00 https://www.bstquarterly.com/article/trend-toward-better-responses-in-subarachnoid-hemorrhage-patients-treated-with-25-human-albumin-pilot-study/ 2025-09-24T18:17:44+00:00 https://www.bstquarterly.com/article/inhibitors-dont-differ-for-previously-untreated-patients-given-plasma-derived-and-recombinant-factor-viii-systematic-review/ 2025-09-24T18:15:19+00:00 https://www.bstquarterly.com/article/over-half-of-u-s-hemophilia-treatment-centers-do-not-follow-nhf-guidelines-for-factor-viii-prophylaxis-in-severe-hemophilia-a/ 2025-09-24T18:12:02+00:00 https://www.bstquarterly.com/article/life-interrupted/ 2025-09-24T17:57:09+00:00 https://www.bstquarterly.com/article/human-plasma-products-two-decades-of-unsurpassed-safety/ 2025-09-24T16:44:29+00:00 https://www.bstquarterly.com/article/myths-and-facts-heart-disease/ 2025-09-24T16:23:45+00:00 https://www.bstquarterly.com/article/lifelong-need-for-ig-weighing-the-pros-and-cons/ 2025-09-24T16:10:10+00:00 https://www.bstquarterly.com/article/proactive-screenings-for-womens-health/ 2025-09-24T14:49:24+00:00 https://www.bstquarterly.com/article/risky-business/ 2025-09-24T14:36:29+00:00 https://www.bstquarterly.com/article/the-drug-shortage-crisis/ 2025-09-24T14:20:59+00:00 https://www.bstquarterly.com/article/the-growing-threat-of-counterfeit-drugs/ 2025-09-24T14:08:39+00:00 https://www.bstquarterly.com/article/povidine-iodine-prep-pads-are-voluntarily-recalled/ 2025-09-24T13:16:52+00:00 https://www.bstquarterly.com/article/clinical-trials-update/ 2025-09-24T12:44:06+00:00 https://www.bstquarterly.com/article/immunotherapy-may-help-to-treat-alzheimers/ 2025-09-24T12:30:27+00:00 https://www.bstquarterly.com/article/albumin-can-be-grown-in-rice/ 2025-09-24T12:21:12+00:00 https://www.bstquarterly.com/article/unicef-lists-vaccine-prices-to-drive-down-cost/ 2025-09-23T21:08:39+00:00 https://www.bstquarterly.com/article/more-evidence-of-an-autism-immune-component/ 2025-09-23T21:04:41+00:00 https://www.bstquarterly.com/article/combined-ivig-treatment-effective-to-treat-kawasaki-disease/ 2025-09-23T21:00:08+00:00 https://www.bstquarterly.com/article/google-invests-in-counterfeit-drug-fighting-technology/ 2025-09-23T19:50:40+00:00 https://www.bstquarterly.com/article/people-with-jobs-syndrome-have-impaired-immune-memory/ 2025-09-23T19:46:25+00:00 https://www.bstquarterly.com/article/fda-approves-supplemental-test-for-chagas-disease/ 2025-09-23T19:41:52+00:00 https://www.bstquarterly.com/article/fda-approves-pneumococcal-vaccine-for-adults-50-plus/ 2025-09-23T19:30:32+00:00 https://www.bstquarterly.com/article/2012-vaccine-schedule-for-children-is-released/ 2025-09-23T19:26:35+00:00 https://www.bstquarterly.com/article/u-s-sets-new-goals-for-a-healthier-nation/ 2025-09-23T19:20:23+00:00 https://www.bstquarterly.com/article/fda-approves-advate-to-treat-hemophilia-a/ 2025-09-23T19:17:44+00:00 https://www.bstquarterly.com/article/fda-approves-first-quadrivalent-flu-vaccine/ 2025-09-23T19:14:50+00:00 https://www.bstquarterly.com/article/new-rule-requires-plain-language-in-describing-health-plan-benefits-and-coverage/ 2025-09-23T19:01:57+00:00 https://www.bstquarterly.com/article/initiatives-to-lower-medicaid-costs-and-improve-care/ 2025-09-23T18:58:34+00:00 https://www.bstquarterly.com/article/partnership-for-patients-meeting-participant-goal/ 2025-09-23T18:52:39+00:00 https://www.bstquarterly.com/article/new-rules-simplify-healthcare-paperwork/ 2025-09-23T18:40:13+00:00 https://www.bstquarterly.com/article/court-rules-for-nih-in-stem-cell-research/ 2025-09-23T18:36:54+00:00 https://www.bstquarterly.com/article/immunization-an-era-of-innovation/ 2025-09-23T17:37:38+00:00 https://www.bstquarterly.com/article/biotests-investigational-10-liquid-ivig-assessed-in-patients-with-pidd/ 2025-09-23T17:33:38+00:00 https://www.bstquarterly.com/article/immunogenicity-and-safety-of-quadrivalent-live-attenuated-influenza-vaccine-in-children/ 2025-09-23T17:30:01+00:00 https://www.bstquarterly.com/article/intravenous-immunoglobulin-protects-neurons-against-amyloid-beta-peptide-toxicity-in-vitro-and-murine-studies/ 2025-09-23T17:26:47+00:00 https://www.bstquarterly.com/article/hiv-a-physicians-perspective-2/ 2025-09-23T17:17:59+00:00 https://www.bstquarterly.com/article/hiv-a-patients-perspective-3/ 2025-09-23T17:10:10+00:00 https://www.bstquarterly.com/article/quadrivalent-flu-vaccines-four-means-more-protection/ 2025-09-23T16:56:53+00:00 https://www.bstquarterly.com/article/influenza-past-present-and-future/ 2025-09-23T16:38:58+00:00 https://www.bstquarterly.com/article/myths-and-facts-lyme-disease/ 2025-09-23T16:24:24+00:00 https://www.bstquarterly.com/article/understanding-and-treating-ig-side-effects/ 2025-09-23T15:28:10+00:00 https://www.bstquarterly.com/article/the-acas-impact-on-vaccine-administration-and-reimbursement/ 2025-09-23T15:04:15+00:00 https://www.bstquarterly.com/article/immunization-innovation-advancements-in-science-and-policy-show-potential/ 2025-09-23T14:40:55+00:00 https://www.bstquarterly.com/article/vaccine-update-5/ 2025-09-23T14:26:13+00:00 https://www.bstquarterly.com/article/csls-rvlla-fp-granted-orphan-drug-designation/ 2025-09-23T14:18:13+00:00 https://www.bstquarterly.com/article/positive-results-for-phase-ii-clinical-trial-for-itp-patients/ 2025-09-23T14:15:24+00:00 https://www.bstquarterly.com/article/new-vaccine-may-prevent-cancer/ 2025-09-23T14:13:16+00:00 https://www.bstquarterly.com/article/smallpox-vaccine-extends-life-in-cancer-trial/ 2025-09-23T14:10:45+00:00 https://www.bstquarterly.com/article/slow-release-of-ig-may-delay-alzheimers-disease/ 2025-09-23T14:08:11+00:00 https://www.bstquarterly.com/article/cangene-recalls-hepagam-b-product-lots/ 2025-09-23T14:05:13+00:00 https://www.bstquarterly.com/article/hhs-delays-icd-10-compliance-date/ 2025-09-23T14:02:01+00:00 https://www.bstquarterly.com/article/online-marketplaces-make-medicaid-eligibility-easier/ 2025-09-23T13:58:13+00:00 https://www.bstquarterly.com/article/federal-court-to-reconsider-genetics-patents/ 2025-09-23T12:27:32+00:00 https://www.bstquarterly.com/article/states-urged-to-prepare-for-health-insurance-exchanges/ 2025-09-22T20:22:53+00:00 https://www.bstquarterly.com/article/new-texas-law-for-meningitis-vaccine/ 2025-09-22T20:22:07+00:00 https://www.bstquarterly.com/article/alzheimers-research-receives-more-funding/ 2025-09-22T19:45:25+00:00 https://www.bstquarterly.com/article/the-human-and-economic-value-of-healthcare-innovation/ 2025-09-22T18:39:13+00:00 https://www.bstquarterly.com/article/ivig-discontinued-much-less-frequently-than-methylprednisolone-for-cidp/ 2025-09-22T18:17:45+00:00 https://www.bstquarterly.com/article/rix-fp-protein-exhibits-prolonged-circulating-half-life-in-hemophilia-b-patients/ 2025-09-22T18:15:01+00:00 https://www.bstquarterly.com/article/2010-2011-trivalent-influenza-vaccine-with-all-three-vaccine-strains-was-moderately-effective/ 2025-09-22T18:12:19+00:00 https://www.bstquarterly.com/article/crohns-disease-a-physicians-perspective/ 2025-09-22T18:09:04+00:00 https://www.bstquarterly.com/article/the-road-to-remission/ 2025-09-22T18:02:41+00:00 https://www.bstquarterly.com/article/shocking-a-newer-hetastarch-product-is-nephrotoxic-and-deadly-in-severe-sepsis/ 2025-09-22T17:28:44+00:00 https://www.bstquarterly.com/article/myths-and-facts-asthma/ 2025-09-22T17:11:41+00:00 https://www.bstquarterly.com/article/infusion-environments-comparing-costs-safety-and-privacy/ 2025-09-22T16:56:39+00:00 https://www.bstquarterly.com/article/an-update-on-meningitis/ 2025-09-22T16:50:57+00:00 https://www.bstquarterly.com/article/ivig-reduces-infections-following-bsab-therapies-in-multiple-myeloma-patients/ 2025-09-22T13:38:55+00:00 https://www.bstquarterly.com/article/fda-approves-mercks-keytruda-qlex-for-solid-tumor-indications/ 2025-09-22T13:36:47+00:00 https://www.bstquarterly.com/article/autoimmune-diseases-exploring-treatment-options/ 2025-09-18T18:57:46+00:00 https://www.bstquarterly.com/article/blending-alternative-and-mainstream-therapies/ 2025-09-18T18:39:17+00:00 https://www.bstquarterly.com/article/companion-diagnostics-the-future-of-personalized-medicine/ 2025-09-18T18:28:08+00:00 https://www.bstquarterly.com/article/medical-breakthroughs-from-concept-to-commercialization/ 2025-09-18T18:08:42+00:00 https://www.bstquarterly.com/article/states-issue-their-own-guidance-about-covid-19-vaccines/ 2025-09-18T18:02:39+00:00 https://www.bstquarterly.com/article/vaccine-may-halt-autoimmune-disease/ 2025-09-18T17:02:28+00:00 https://www.bstquarterly.com/article/study-confirms-breast-cancer-and-autoimmune-arthritis-link/ 2025-09-18T16:59:13+00:00 https://www.bstquarterly.com/article/revised-cms-rules-to-decrease-healthcare-costs/ 2025-09-18T16:58:23+00:00 https://www.bstquarterly.com/article/personalized-immune-mouse-to-study-autoimmune-disease/ 2025-09-18T16:56:52+00:00 https://www.bstquarterly.com/article/osteoporosis-drug-may-help-kill-flu-viruses/ 2025-09-18T16:55:21+00:00 https://www.bstquarterly.com/article/new-possible-cause-for-unexplained-miscarriages/ 2025-09-18T16:54:31+00:00 https://www.bstquarterly.com/article/new-law-aims-to-accelerate-drug-approvals-and-enhance-safety/ 2025-09-18T16:53:20+00:00 https://www.bstquarterly.com/article/more-young-adults-now-have-health-insurance/ 2025-09-18T16:52:19+00:00 https://www.bstquarterly.com/article/malaria-vaccine-close-to-reality/ 2025-09-18T16:51:26+00:00 https://www.bstquarterly.com/article/hhs-recognizes-facilities-for-preventing-hais/ 2025-09-18T16:50:34+00:00 https://www.bstquarterly.com/article/hhs-creates-centers-to-safeguard-public/ 2025-09-18T16:49:50+00:00 https://www.bstquarterly.com/article/gene-therapy-may-reverse-hemophilia/ 2025-09-18T16:49:12+00:00 https://www.bstquarterly.com/article/funds-committed-to-expand-community-health-centers/ 2025-09-18T16:48:33+00:00 https://www.bstquarterly.com/article/fundraising-effort-in-progress-for-treating-critical-care-patients/ 2025-09-18T16:47:42+00:00 https://www.bstquarterly.com/article/flu-vaccine-coverage-well-below-healthy-people-2020-objectives/ 2025-09-18T16:46:58+00:00 https://www.bstquarterly.com/article/feds-take-additional-steps-to-combat-alzheimers-disease/ 2025-09-18T16:46:21+00:00 https://www.bstquarterly.com/article/bri-and-novo-nordisk-collaborate-on-autoimmune-disease-research/ 2025-09-18T16:45:34+00:00 https://www.bstquarterly.com/article/brain-tumor-vaccine-shows-promise-in-trials/ 2025-09-18T16:44:50+00:00 https://www.bstquarterly.com/article/champions-help-consumers-understand-new-insurance-marketplace/ 2025-09-17T20:46:11+00:00 https://www.bstquarterly.com/article/study-shows-pfizers-updated-mrna-covid-19-vaccine-elicits-strong-immune-response/ 2025-09-15T18:42:41+00:00 https://www.bstquarterly.com/article/study-finds-meningitis-vaccine-shows-promise/ 2025-09-10T18:50:45+00:00 https://www.bstquarterly.com/article/drug-granted-fast-track-approval-to-treat-refractory-lupus-nephritis/ 2025-09-10T18:46:45+00:00 https://www.bstquarterly.com/article/mrna-based-vaccine-plus-keytruda-reduces-the-risk-of-melanoma-spread/ 2025-09-10T18:41:06+00:00 https://www.bstquarterly.com/article/fda-approves-roches-columvi-to-treat-diffuse-large-b-cell-lymphoma-in-adults/ 2025-09-10T18:35:18+00:00 https://www.bstquarterly.com/article/first-subcutaneous-injectable-approved-to-treat-generalized-myasthenia-gravis/ 2025-09-10T18:28:15+00:00 https://www.bstquarterly.com/article/pfizers-litfulo-for-severe-alopecia-areata-approved-by-fda/ 2025-09-10T18:19:36+00:00 https://www.bstquarterly.com/article/sandoz-launches-hyrimoz-biosimilar-to-humira/ 2025-09-10T18:16:15+00:00 https://www.bstquarterly.com/article/researchers-discover-how-melanoma-evades-the-immune-system/ 2025-09-10T18:12:19+00:00 https://www.bstquarterly.com/article/fda-converts-leqembi-to-traditional-approval-to-treat-alzheimers/ 2025-09-10T18:08:32+00:00 https://www.bstquarterly.com/article/personalized-digital-care-program-improves-outcomes-in-long-covid-and-autoimmune-disease/ 2025-09-10T18:04:00+00:00 https://www.bstquarterly.com/article/study-shows-positive-results-for-mrna-based-combination-influenza-and-covid-19-vaccine-2/ 2025-09-10T17:57:59+00:00 https://www.bstquarterly.com/article/aanem-publishes-new-guidelines-for-use-of-ivig-for-neuromuscular-disorders/ 2025-09-10T17:52:45+00:00 https://www.bstquarterly.com/article/scientists-identify-driver-of-inflammatory-bowel-disease/ 2025-09-10T17:46:57+00:00 https://www.bstquarterly.com/article/study-shows-not-all-ivig-products-are-effective-in-treating-alzheimers/ 2025-09-10T17:42:54+00:00 https://www.bstquarterly.com/article/inverse-vaccine-may-reverse-autoimmune-diseases/ 2025-09-10T17:38:12+00:00 https://www.bstquarterly.com/article/fda-approves-cryocheck-factor-viii-deficient-plasma-with-vwf/ 2025-09-10T17:32:38+00:00 https://www.bstquarterly.com/article/fda-approves-biosimilar-to-actmra/ 2025-09-10T17:23:35+00:00 https://www.bstquarterly.com/article/modernas-influenza-covid-19-vaccine-demonstrates-immunogenecity/ 2025-09-10T17:17:52+00:00 https://www.bstquarterly.com/article/intranasal-covid-19-vaccine-shows-high-seroresponse/ 2025-09-10T17:12:41+00:00 https://www.bstquarterly.com/article/ivig-reduces-infection-risk-during-anti-bcma-treatment-for-mm/ 2025-09-10T17:07:55+00:00 https://www.bstquarterly.com/article/complement-c5-inhibitor-zilucoplan-is-approved-by-fda-to-treat-mg/ 2025-09-10T17:02:07+00:00 https://www.bstquarterly.com/article/new-vaccine-could-fight-hospital-acquired-infections-by-boosting-the-immune-system/ 2025-09-10T16:52:16+00:00 https://www.bstquarterly.com/article/efgartigimod-efficacious-in-treating-chronic-immune-thombocytopenia/ 2025-09-03T20:08:37+00:00 https://www.bstquarterly.com/article/fda-approves-zepbound-as-a-new-weight-loss-drug/ 2025-09-03T13:25:39+00:00 https://www.bstquarterly.com/article/first-vaccine-for-mosquito-born-viral-disease-is-approved-by-fda/ 2025-09-02T21:03:52+00:00 https://www.bstquarterly.com/article/first-treatment-approved-for-genetic-clotting-disorder/ 2025-09-02T20:58:49+00:00 https://www.bstquarterly.com/article/protein-identified-that-can-cause-cancer-cells-to-die/ 2025-09-02T20:54:08+00:00 https://www.bstquarterly.com/article/fourth-dose-of-covid-19-vaccine-increases-protection-in-rheumatic-disease-patients/ 2025-09-02T20:48:28+00:00 https://www.bstquarterly.com/article/fda-approves-yimmugo-an-ivig-product-to-treat-primary-immunodeficiencies/ 2025-09-02T20:41:57+00:00 https://www.bstquarterly.com/article/nasal-covid-19-vaccine-trial-opens/ 2025-09-02T20:35:38+00:00 https://www.bstquarterly.com/article/new-pneumococcal-vaccine-capvaxive-approved-by-fda/ 2025-09-02T19:59:25+00:00 https://www.bstquarterly.com/article/drug-to-treat-acute-pancreatitis-granted-fast-track-designation-by-fda/ 2025-09-02T19:52:25+00:00 https://www.bstquarterly.com/article/universal-flu-vaccine-may-be-available-in-five-years/ 2025-09-02T19:45:22+00:00 https://www.bstquarterly.com/article/plasma-therapies-from-supply-to-dosing-and-reimbursement/ 2025-09-02T19:08:56+00:00 https://www.bstquarterly.com/article/study-shows-new-scig-drug-evogam-safe-and-efficacious/ 2025-09-02T19:02:15+00:00 https://www.bstquarterly.com/article/study-reveals-clinical-manifestations-that-lead-to-delayed-diagnosis-in-cvid-patients/ 2025-09-02T18:57:24+00:00 https://www.bstquarterly.com/article/ivig-as-effective-as-plasma-exchange-in-treating-guillain-barre-syndrome/ 2025-09-02T18:52:09+00:00 https://www.bstquarterly.com/article/fda-approves-leqembi-iqlik-to-treat-early-alzheimers-disease/ 2025-09-02T18:46:48+00:00 https://www.bstquarterly.com/article/the-plasma-industry-investing-today-to-ensure-ig-and-albumin-supply-for-tomorrow/ 2025-09-02T18:45:13+00:00